SII plans to launch new Covid vax by September

June 17, 2021 16:14

The Serum Insititute of India (SII) hopes to introduce Covavax in the country by September which is a version of the US firm Novavax's COVID19 vaccine candidate. SII also plans to start clinical trials of the Novavax shot for children in July.

The United States-based Novavax on Monday said that its nano-particle protein based Covid-19 vaccine candidate has demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials.

In India its partner Serum Institute of India has started manufacturing the vaccine it has named Covovax already.

In fact, the Centre expects availability of 200 million doses of Covovax between August and December.

India will allow entry of this vaccine here once the US Food and Drug Administration approves it.

« Back to LIVE

TOP STORIES

Nepal's Rs 100 note to feature new map with disputed Indian territories

India maintains Lipulekh, Kalapani and Limpiyadhura belong to it.

Cong social media team coordinator held for Amit Shah fake video

Arun Beereddy (37), a native of Telangana's Hyderabad, was arrested from Delhi. He handles the 'Spirit of Congress' account on X, the official said.

IPL 2024: What is going wrong for MI? Here's what Hardik said...

Mumbai Indians skipper Hardik Pandya seemed to be at a loss for words to explain the reasons for his team's disastrous showing in IPL 2024 so far.

IPL PIX: Clinical KKR outclass MI; inch closer to play-offs!

Kolkata Knight Riders outclassed Mumbai Indians by 24 runs in the IPL 2024 match on Friday.

Canadian police arrest 3 suspects in Nijjar murder case: Media report

Three people have been arrested and charged in the killing of Sikh activist Nijjar, CTV News quoted a senior government source as saying.